@article {Merino-Amador2020.11.18.20230375, author = {Paloma Merino-Amador and Jes{\'u}s Guinea and Irene Mu{\~n}oz-Gallego and Patricia Gonz{\'a}lez-Donapetry and Juan-Carlos Gal{\'a}n and Nerea Antona and Gustavo Cilla and Silvia Hern{\'a}ez-Crespo and Jos{\'e}-Luis D{\'\i}az-de Tuesta and Ana Gual-de Torrella and Fernando Gonz{\'a}lez-Romo and Pilar Escribano and Miguel {\'A}ngel S{\'a}nchez-Castellano and Mercedes Sota-Busselo and Alberto Delgado-Iribarren and Julio Garc{\'\i}a and Rafael Cant{\'o}n and Patricia Mu{\~n}oz and M Dolores Folgueira and Manuel Cuenca-Estrella and Jes{\'u}s Oteo-Iglesias and Spanish Panbio{\texttrademark} COVID-19 validation group {\textdaggerdbl}}, title = {Multicenter evaluation of the Panbio{\texttrademark} COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection}, elocation-id = {2020.11.18.20230375}, year = {2020}, doi = {10.1101/2020.11.18.20230375}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The standard RT-PCR assay for COVID-19 is laborious and time-consuming, limiting the availability of testing. Rapid antigen-detection tests are faster and less expensive; however, the reliability of these tests must be validated before they can be used widely. The objective of this study was to determine the reliability of the PanbioTM COVID-19 Ag Rapid Test Device (PanbioRT) (Abbott) for SARS-CoV-2 in nasopharyngeal swab specimens. This was a prospective multicenter study in ten Spanish university hospitals of patients from hospital units with clinical symptoms or epidemiological criteria for COVID-19. Patients whose onset of symptoms or exposure was more than 7 days earlier were excluded. Two nasopharyngeal exudate samples were taken to perform the PanbioRT and a diagnostic RT-PCR test. Among the 958 patients studied, 359 (37.5\%) were positive by RT-PCR and 325 (33.9\%) were also positive by the PanbioRT. Agreement was 95.7\% (kappa score: 0.90). All 34 false-negative PanbioRT results were in symptomatic patients, with 23.5\% of them at 6{\textendash}7 days since the onset of symptoms and 58.8\% presenting CT \>30 values for RT-PCR, indicating a low viral load. Overall sensitivity and specificity for the PanbioRT were 90.5\% and 98.8\%, respectively. The PanbioRT provides good clinical performance as a point-of-care test, with even more reliable results for patients with a shorter clinical course of the disease or a higher viral load. While this study has had a direct impact on the national diagnostic strategy for COVID-19 in Spain, the results must be interpreted based on the local epidemiological context.Competing Interest StatementRC has participate in educational programs organized by Abbot. The other authors have none to declare.Funding StatementThis study did not receive public or private funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee for Healthcare (CEAS) of Hospital Clinico San CarlosAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data mentioned in the manuscript are available upon request to the corresponding author}, URL = {https://www.medrxiv.org/content/early/2020/11/20/2020.11.18.20230375}, eprint = {https://www.medrxiv.org/content/early/2020/11/20/2020.11.18.20230375.full.pdf}, journal = {medRxiv} }